Effects of Different ACE Inhibitors on Endothelin-1 and Nitric Oxide in Human Cells
Author Information
Author(s): Desideri Giovambattista, Grassi Davide, Croce Giuseppe, Bocale Raffaella, Tiberti Sergio, Evangelista Stefano, Necozione Stefano, Di Orio Ferdinando, Ferri Claudio
Primary Institution: University of L'Aquila
Hypothesis
The study investigates how different angiotensin converting enzyme inhibitors (ACE-I) affect endothelin-1 and nitric oxide balance in human vascular endothelial cells.
Conclusion
Zofenoprilat is more effective than other ACE inhibitors in improving the balance of endothelin-1 and nitric oxide in human vascular endothelial cells.
Supporting Evidence
- All four tested ACE inhibitors reduced endothelin-1 secretion and increased nitric oxide production.
- Zofenoprilat was more effective than the other ACE inhibitors in reducing endothelin-1 secretion.
- Zofenoprilat also significantly increased nitric oxide metabolite production compared to other ACE inhibitors.
- The effects of ACE inhibitors on endothelin-1 and nitric oxide production are mediated by bradykinin B2 receptor activation.
Takeaway
Some medicines can help blood vessels work better by changing the levels of certain chemicals in the body. One medicine, zofenoprilat, works better than others at this.
Methodology
The study involved testing the effects of four ACE inhibitors on human vascular endothelial cells, measuring endothelin-1 secretion and nitric oxide production.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website